Vistagen Therapeutics, Inc. (VTGN)
4.54
+0.25
(+5.83%)
USD |
NASDAQ |
Dec 09, 16:00
4.55
+0.01
(+0.22%)
After-Hours: 18:24
Vistagen Therapeutics Profit Margin (Quarterly): -7.53K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | -40.15% |
| XOMA Royalty Corp. | -- |
| Omeros Corp. | -- |
| GeoVax Labs, Inc. | -- |
| Daré Bioscience, Inc. | -154.9K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -76.57% |
| Return on Assets | -67.18% |
| Return on Invested Capital | -74.76% |
| Gross Profit Margin (Quarterly) | 28.29% |
| Operating Margin (Quarterly) | -7.77K% |
| Return on Net Operating Assets | -3.25K% |